Displaying items by tag: department of neurology

While demand for medical cannabis products grows in the United States, a UAB study suggests health care providers are ill-equipped to provide guidance.
Dual antiplatelet therapy after percutaneous coronary intervention uses aspirin and one other drug, among several choices. But which drug is best to use?
UAB researchers say lack of financial resources and health insurance, as well as living in the South, are keys to disparities in epilepsy care.
One woman’s mysterious illness left her searching for answers, and all it took was having someone listen.
Two UAB neuroscientists have been included in a listing of 100 of the most inspiring black scientists in the nation.
Standaert directs the Morris K. Udall Center of Excellence in Parkinson’s Disease Research, one of eight such centers funded by the National Institute of Neurological Disorders and Stroke.

Adam Gerstenecker has been honored by two organizations with early career awards in neuropsychology.

UAB is named one of 44 centers of excellence worldwide for Guillain-Barré Syndrome.

Genome sequencing leads to new understanding of genetic risk factors that might play a role in the risk of dementia.
UAB Parkinson’s disease expert David Standaert and an Italian colleague have received the fifth annual Bachmann-Strauss Prize for Excellence in Dystonia Research.
A UAB researcher’s promising data shows improvement of Duchenne muscular dystrophy symptoms in mice and zebrafish using an experimental drug.
The nation faces a dire need for movement disorder specialists as the incidence of diseases such as Parkinson’s continues to increase.
UAB researchers have found a previously unknown gene variant that appears to contribute to movement disorders.
UAB has enrolled more than 40 participants in its Alabama Udall Center clinical research core.
A specialized clinic in a tertiary hospital is effective at treating patients from five states.
Researchers at UAB are looking at the health of brain structures called dendritic spines in the battle against Alzheimer’s disease.
Scientists at UAB have homed in on a protein structure in the brain that may be a promising target for new therapies to treat Parkinson’s disease.
Page 3 of 12